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Clinical PerspectiveWhat Is New?Certificate of need (CON) programs are statewide regulations that aim to prevent overuse and improve quality.We assessed if states with CON regulations had significant differences in percutaneous coronary intervention appropriateness and rates of post‐procedural adverse outcomes as compared with states without CON regulations.We found CON regulations are associated with only modest differences in the appropriateness and outcomes of percutaneous coronary intervention procedures.What Are the Clinical Implications?Our study suggests there may be limited efficacy in CON regulations as public policies to improve percutaneous coronary intervention appropriateness and outcomes.Additional research is needed to evaluate whether the effectiveness of CON regulations for facilities performing invasive cardiac procedures outweigh the opportunity costs of implantation and maintenance.

Introduction {#jah33788-sec-0008}
============

More than 600 000 percutaneous coronary interventions (PCIs) are performed in the United States each year, accounting for over \$12 billion in healthcare spending.[1](#jah33788-bib-0001){ref-type="ref"} In part because of concerns about potential overuse of PCIs, the American College of Cardiology, American Heart Association, and other professional organizations released the appropriate use criteria (AUC) for coronary revascularization.[1](#jah33788-bib-0001){ref-type="ref"}, [2](#jah33788-bib-0002){ref-type="ref"}, [3](#jah33788-bib-0003){ref-type="ref"} The AUC are intended to support improved selection of patients for PCI, particularly among patients with stable coronary artery disease. Although the proportion of rarely appropriate PCI (the AUC used the term "inappropriate" previously) has improved over time, nearly 1 in 7 non‐acute PCIs performed in 2014 were classified as rarely appropriate, which varied substantially across hospitals.[4](#jah33788-bib-0004){ref-type="ref"} These findings highlight the continued need to identify strategies to ensure that PCI procedures are being performed in patients in whom the benefits clearly outweigh the potential risks.

Certificate of need (CON) programs are 1 strategy to control costs, prevent overuse, and improve quality by regulating new facilities and capital equipment.[5](#jah33788-bib-0005){ref-type="ref"}, [6](#jah33788-bib-0006){ref-type="ref"} At present, 36 states have a CON program, and 26 states have CON regulations pertaining to cardiac services involving cardiac catheterization laboratories.[7](#jah33788-bib-0007){ref-type="ref"} By regulating the supply of PCI programs, CON policies may reduce the number of excess cardiac catheterization facilities, thereby minimizing financial pressures of those facilities that may influence higher number of appropriate PCIs. Therefore, one might expect that patients undergoing PCI in states with cardiac CON might have more favorable appropriateness ratings and quality as assessed by lower rates of adverse outcomes compared with patients treated in states without cardiac CON. Investigators have examined the association of CON regulations with appropriateness and outcomes, but the studies have been inconsistent and did not use contemporary updated AUC criteria.[1](#jah33788-bib-0001){ref-type="ref"}, [5](#jah33788-bib-0005){ref-type="ref"}, [8](#jah33788-bib-0008){ref-type="ref"}, [9](#jah33788-bib-0009){ref-type="ref"}, [10](#jah33788-bib-0010){ref-type="ref"}

To address these gaps in knowledge, we used data from the American College of Cardiology National Cardiovascular Data Registry\'s CathPCI Registry. Specifically, we compared the appropriateness of procedures performed for both acute and non‐acute indications in states with and without cardiac CON regulations. Given known associations of patient outcome variations with PCI appropriateness,[11](#jah33788-bib-0011){ref-type="ref"} we also investigated whether state CON status was associated with differences in adverse outcomes including peri‐procedural complications and in‐hospital mortality. We hypothesized that there will be modest differences in PCI appropriateness such as states without CON will have a lower proportion of rarely appropriate PCIs and lower rates of adverse outcomes compared with states without CON regulation.

Methods {#jah33788-sec-0009}
=======

Data Sources {#jah33788-sec-0010}
------------

The National Cardiovascular Data Registry\'s CathPCI registry is cosponsored by the American College of Cardiology and the Society for Cardiovascular Angiography and Interventions and collects detailed information on patient and hospital characteristics, clinical presentations, treatments, and outcomes from participating hospitals in the United States.[12](#jah33788-bib-0012){ref-type="ref"}, [13](#jah33788-bib-0013){ref-type="ref"} For this analysis, we used data from PCIs performed between January 1, 2010 and December 31, 2011 using Version 4.0 of the data collection form. This study period was chosen to correlate with availability of CON information that was validated for accuracy. The data and analytical methods will not be made available to other researchers for the purpose of replicating the results of this study.

Study Design and Population {#jah33788-sec-0011}
---------------------------

We performed a cross‐sectional analysis of all hospitals in the CathPCI registry that reported at least 20 PCI procedures during the study time period, excluding 34 low volume hospitals and resulting in a total of 1297 facilities included in the analysis. Among patients with \>1 PCI performed during a hospitalization, we only considered information from the initial procedure.

CON Regulation {#jah33788-sec-0012}
--------------

Information about state\'s CON regulation was obtained through reports published by the National Conference of State Legislation.[7](#jah33788-bib-0007){ref-type="ref"} Individual states and the District of Columbia were categorized according to whether they had cardiac catheterization CON regulations from 2010 to 2011. All information was verified using published information from individual states and from the American Health Planning Association National Directory.[14](#jah33788-bib-0014){ref-type="ref"} No states discontinued or initiated CON regulations pertaining to cardiac catheterization during the study period.

We further characterized states with CON regulations into 3 groups according to the stringency of the CON regulations (high, moderate, and low stringency; Table [S1](#jah33788-sup-0001){ref-type="supplementary-material"}).[5](#jah33788-bib-0005){ref-type="ref"} Stringency categories were assigned based on data from 2001 to 2002, the most recent time period for which state CON stringency had been assessed.[15](#jah33788-bib-0015){ref-type="ref"} A total of 3 states met criteria for high CON stringency, 7 states met criteria for moderate CON stringency, and 16 met criteria for low CON stringency.

Appropriateness {#jah33788-sec-0013}
---------------

We classified the appropriateness of PCI procedures using the 2012 AUC. The committee defined appropriateness as the following: *Coronary revascularization is appropriate when the expected benefits, in terms of survival or health outcomes (symptoms, functional status, and/or quality of life) exceed the expected negative consequences of the procedure*. In the process of creating the criteria, a 21‐member expert panel designated the appropriateness of coronary revascularization for the most common clinical scenarios encountered in clinical practice for consideration of PCI. Additional details about the methodology on the AUC has been previously described elsewhere.[2](#jah33788-bib-0002){ref-type="ref"}, [4](#jah33788-bib-0004){ref-type="ref"} The AUC criteria classify the majority of PCIs performed in the context of whether the procedure was performed for an acute indication (ie, acute coronary syndrome \[ACS\] including myocardial infarction and unstable angina) or non‐acute indication (ie, non‐ACS). Procedures without the appropriate requisite data were considered unmappable and excluded from our analyses.

Outcomes Measures {#jah33788-sec-0014}
-----------------

We examined in‐hospital procedural complications and mortality. Procedural complications included vascular complications requiring treatment, red blood cell/whole blood transfusion, major bleeding event within 72 hours, stroke, and emergency or salvage coronary artery bypass grafting. We also calculated a risk‐adjusted composite end point of any adverse outcome (complication and death). Risk‐adjusted outcomes were performed in a manner consistent with prior studies and adjusted for variables previously shown to be associated with risk of adverse events (Table [S2](#jah33788-sup-0001){ref-type="supplementary-material"}).[1](#jah33788-bib-0001){ref-type="ref"}, [9](#jah33788-bib-0009){ref-type="ref"}, [16](#jah33788-bib-0016){ref-type="ref"}

Statistical Analysis {#jah33788-sec-0015}
--------------------

We compared patient and hospital characteristics of PCI procedures performed in states with and without CON regulations for cardiac catheterization using t test and *x* ^*2*^ analyses. Patient characteristics included information about demographics, clinical presentation, comorbid diseases, and relevant past medical history and risk factors. Hospital characteristics included geographic region, teaching status, and cardiac surgery capabilities. We compared the proportions of PCI procedures classified as appropriate, may be appropriate, and rarely appropriate in states with and without CON regulations, and further stratified analyses by whether the procedure was performed for acute and non‐acute indications. We repeated analyses stratifying patients in CON states by state CON stringency. Finally, we repeated these analysis adjusting for within‐facility clustering and hospital characteristics.

We also compared unadjusted PCI complications and mortality events, as described previously, in patients in states with CON and without CON status. We then used multivariate logistical regression to examine the association of CON status with the composite end point of any adverse outcome including death. Analyses were conducted using SAS version 9.3 (SAS Institute, Cary, NC). All reported *P* values are reported as 2‐sided with significance at *P*\<0.05. The Yale University Human Investigations Committee approved analysis of a limited National Cardiovascular Data Registry\'s data set for research and waived the requirement for informed consent.

Results {#jah33788-sec-0016}
=======

Patient Demographics {#jah33788-sec-0017}
--------------------

A total of 1 268 554 PCI procedures performed at 1297 facilities between January 2010 and December 2011 met criteria for inclusion in this study. In our analysis, 53.2% of patients were from 26 states with CON regulations, 67.5% were male, 88.0% were white, and the mean age was aged 64.7 years (Table [1](#jah33788-tbl-0001){ref-type="table"}). Compared with patients treated in non‐CON states, patients treated in CON states were modestly more likely to be a current or recent smoker, have hypertension, diabetes mellitus, hyperlipidemia, and a history of prior myocardial infarction or PCI. Patients treated in non‐CON states were more likely to have been transferred from an outside emergency department. Median and interquartile ranges (25th, 75th) of PCI volume performed in facilities in states with CON was 445 (215--824) and in states without CON, 385 (198--611). A higher proportion of PCIs performed in states with CON regulations were considered elective compared with states without CON regulations. Additional clinical demographics and clinical characteristics of patients before PCI are shown in Table [1](#jah33788-tbl-0001){ref-type="table"}.

###### 

Patient Baseline Clinical Characteristics in States With and Without CON Programs

  Variable                                             Total       CON      No CON                      
  ---------------------------------------------------- ----------- -------- --------- ------- --------- -------
  n                                                    1 268 795   100.00   594 411   46.85   674 384   53.15
  Demographics                                                                                          
  Age, y: Mean (SD)                                    64.70       12.08    64.11     12.03   65.22     12.11
  Sex:Female                                           412 546     32.51    195 517   32.89   217 029   32.18
  Race:White                                           1 115 986   87.96    511 788   86.10   604 198   89.59
  Insurance:Private                                    445 043     35.08    201 347   33.87   243 696   36.14
  History and risk factors                                                                              
  BMI:Mean (SD)                                        29.93       6.18     30.04     6.22    29.84     6.15
  Current/recent smoker (\<1 y)                        349 974     27.60    174 463   29.37   175 511   26.04
  Hypertension                                         1 039 722   81.98    491 856   82.79   547 866   81.28
  Dyslipidemia                                         1 011 549   79.81    477 014   80.34   534 535   79.35
  Family history of CAD                                314 490     24.80    146 894   24.72   167 596   24.86
  Prior MI                                             381 457     30.08    180 856   30.44   200 601   29.76
  Prior HF                                             150 985     11.91    71 195    11.99   79 790    11.84
  Prior valve surgery/procedure                        18 638      1.47     8243      1.39    10 395    1.54
  Prior PCI                                            515 908     40.67    248 062   41.74   267 846   39.72
  Prior CABG                                           234 904     18.52    112 476   18.92   122 428   18.16
  Currently on dialysis                                30 073      2.37     13 818    2.33    16 255    2.41
  Cerebrovascular disease                              156 442     12.34    75 572    12.72   80 870    12.00
  Peripheral artery disease                            159 268     12.56    75 005    12.63   84 263    12.50
  Chronic lung disease                                 192 731     15.20    94 588    15.92   98 143    14.56
  Diabetes mellitus                                    461 911     36.42    220 078   37.04   241 833   35.87
  Clinical evaluation before procedure                                                                  
  CAD presentation                                                                                      
  No symptom, no angina                                105 985     8.35     47 399    7.98    58 586    8.69
  Symptom unlikely to be ischemic                      36 100      2.85     16 767    2.82    19 333    2.87
  Stable angina                                        216 721     17.08    99 158    16.68   117 563   17.44
  Unstable angina                                      472 465     37.24    228 959   38.53   243 506   36.11
  NSTEMI                                               233 281     18.39    108 531   18.26   124 750   18.50
  STEMI or equivalent                                  204 032     16.08    93 491    15.73   110 541   16.39
  Anginal classification w/in 2 wks                                                                     
  No symptoms                                          160 651     12.70    72 341    12.21   88 310    13.12
  CCS I                                                75 136      5.94     29 183    4.93    45 953    6.83
  CCS II                                               248 589     19.65    114 698   19.36   133 381   19.90
  CCS III                                              413 901     32.71    200 995   33.93   212 906   31.64
  CCS IV                                               366 969     29.00    175 133   29.57   191 836   28.51
  Anti‐anginal medications                             870 262     68.62    419 495   70.61   450 767   66.87
  Heart failure w/in 2 wks                             122 348     9.65     54 179    9.12    68 169    10.11
  Cardiomyopathy or LV systolic dysfunction            127 302     10.04    57 431    9.66    69 871    10.36
  Cardiogenic shock w/in 24 h                          24 843      1.96     10 814    1.82    14 029    2.08
  Cardiac arrest w/in 24 h                             24 585      1.94     10 843    1.82    13 742    2.04
  Preoperative evaluation before non‐cardiac surgery   25 473      2.01     11 500    1.94    13 973    2.07
  Stress imaging studies performed                     426 392     33.63    200 516   33.77   225 876   33.51
  PCI procedure                                                                                         
  Transfer from outside ED                             464 013     36.57    206 880   34.80   257 133   38.13
  Hospital status                                                                                       
  Outpatient                                           304 797     24.03    143 413   24.14   161 384   23.94
  Outpatient converted to inpatient                    229 880     18.13    104 494   17.59   125 386   18.60
  Inpatient                                            733 510     57.84    346 173   58.27   387 337   57.46
  PCI status                                                                                            
  Elective                                             558 873     44.07    269 787   45.41   289 086   42.89
  Urgent                                               481 428     37.96    221 510   37.28   259 918   38.56
  Emergency                                            223 759     17.64    101 095   17.02   122 664   18.2
  Salvage                                              4109        0.32     1728      0.29    2381      0.35
  Cardiogenic shock at start of PCI                    28 018      2.21     12 179    2.05    15 839    2.35

BMI indicates body mass index; CABG, coronary artery bypass grafting; CAD, coronary artery disease; CCS, Canadian Cardiovascular Society; CON, certificate of need; ED, emergency department; HF, heart failure; LV, left ventricular; MI, myocardial infarction; NSTEMI, non‐ST‐segment--elevation myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST‐segment--elevation MI.

Association of CON Status With PCI Appropriateness {#jah33788-sec-0018}
--------------------------------------------------

The proportions of procedures that did not have the data elements needed to map to an AUC indication were similar in CON and non‐CON states (11.7% versus 11.1%) .The proportion of PCIs classified as appropriate or maybe appropriate in states with CON regulations was higher than in states without CON (85.2% versus 84.3%, *P*\<0.01) (Table [2](#jah33788-tbl-0002){ref-type="table"}) and a lower proportion of procedures were considered rarely appropriate (3.7% versus 4.0%, *P*\<0.01) ([Figure](#jah33788-fig-0001){ref-type="fig"}A). Absolute differences were larger in patients undergoing PCI for non‐acute indications. In this group, 76.9% of procedures were classified as appropriate or maybe appropriate in states with CON compared with 75.0% in states without CON (*P*\<0.01) (Table [2](#jah33788-tbl-0002){ref-type="table"}). Furthermore, in cases of non‐acute PCI, 23.1% of procedures performed were classified as rarely appropriate ([Figure](#jah33788-fig-0001){ref-type="fig"}B). Among acute PCIs, there were no statistically significant differences between states with and without CON regulations seen in the proportions of procedures considered appropriate (99.4% versus 99.4%) or rarely appropriate (0.6% versus 0.6%). Within CON states, the stringency of CON was associated with differences in PCI appropriateness, both overall and among PCIs performed for non‐acute indications. More stringent CON regulations were associated with a higher proportion of rarely appropriate PCIs although the absolute difference was small (least stringent: 3.75% versus most stringent: 4.03%; *P*\<0.01). Among PCIs performed for non‐acute indications, statewide CON stringency was associated with reduced rates of rarely appropriate PCI such that states with more stringent CON regulations were associated with lower proportions of rarely appropriate PCIs (least stringent: 22.92% versus most stringent: 20.58%; *P*\<0.01) (Table [3](#jah33788-tbl-0003){ref-type="table"}).

###### 

Appropriateness of PCI Procedures Stratified by CON Status

                                  Total       No CON   CON       *P* Value                     
  ------------------------------- ----------- -------- --------- ----------- --------- ------- ----------
  All                                                                                          
  Appropriate use criteria                                                                     
  Appropriate/Maybe appropriate   1 074 517   84.70    568 131   84.26       506 386   85.21   \<0.0001
  Rarely appropriate              49 111      3.87     27 142    4.03        21 969    3.70    
  Acute indications                                                                            
  Appropriate use criteria                                                                     
  Appropriate/Maybe appropriate   929 985     99.37    491 522   99.38       438 463   99.37   0.79
  Rarely appropriate              5860        0.63     3087      0.62        2773      0.63    
  Non‐acute indications                                                                        
  Appropriate use criteria                                                                     
  Appropriate/Maybe appropriate   136 278     75.91    72 263    75.03       64 015    76.93   \<0.0001
  Rarely appropriate              43 251      24.09    24 055    24.97       19 196    23.07   

CON indicates certificate of need.

![**A**, Percentages of rarely appropriate PCIs of all patients by certificate of need status. Horizontal box plot with each dot representing a facility. Dots are stretched vertically to figuratively show a distribution. **B**, Percentages of rarely appropriate PCIs of non‐acute coronary syndrome patients by certificate of need status. Horizontal box plot with each dot representing a facility. Dots are stretched vertically to figuratively show a distribution. PCI indicates percutaneous coronary intervention.](JAH3-8-e010373-g001){#jah33788-fig-0001}

###### 

Appropriateness of PCI Procedures as Stratified by CON Stringency

                                  Total     Less     Moderate   Most      *P* Value                            
  ------------------------------- --------- -------- ---------- --------- ----------- ------- -------- ------- ----------
  All                                                                                                          
  n                               594 306   100.00   347 271    58.43     201 388     33.89   45 647   7.68    
  Appropriate/Maybe appropriate   506 386   85.21    297 324    85.62     170 340     84.58   38 722   84.83   \<0.0001
  Rarely appropriate              21 969    3.70     13 027     3.75      7102        3.53    1840     4.03    
  Acute indications                                                                                            
  n                               441 236   100.00   258 283    58.54     150 464     34.10   32 489   7.36    
  Appropriate/Maybe appropriate   438 463   99.37    256 677    149 551   145 690     99.39   32 235   99.22   0.79
  Rarely appropriate              2773      0.63     1606       0.62      913         0.61    254      0.78    
  Non‐acute indications                                                                                        
  n                               83 211    100.00   49 831     59.89     25 672      30.85   7708     9.26    
  Appropriate/Maybe appropriate   64 015    76.93    38 410     77.08     19 483      75.89   6122     79.42   0.14
  Rarely appropriate              19 196    23.07    11 421     22.92     6189        24.11   1586     20.58   

CON indicates certificate of need; PCI, percutaneous coronary intervention.

After adjustment for hospital clustering and characteristics, CON remained significantly associated with PCI appropriateness in all cases (*P*\<0.05) and in non‐acute PCI (*P\<*0.05). There again was no association between CON and PCI appropriateness in acute causes (*P*=0.94). Within CON states, CON stringency was no longer associated with PCI appropriateness in all cases (*P*=0.95), acute causes (*P*=0.69), and non‐acute cases (*P*=0.78).

Association of CON Status With PCI Outcomes {#jah33788-sec-0019}
-------------------------------------------

Statewide CON regulations were inconsistently associated with unadjusted peri‐ and post‐procedural complication rates. States with CON regulations had significantly higher bleeding events (1.74% versus 1.59%, *P*\<0.01) and a lower proportion of post‐PCI patients requiring emergency or salvage coronary artery bypass grafting (0.27% versus 0.30%, *P*\<0.01) (Table [4](#jah33788-tbl-0004){ref-type="table"}). The proportions of patients experiencing vascular complications, stroke, or requiring a blood transfusion were similar in CON and non‐CON states. (Table [4](#jah33788-tbl-0004){ref-type="table"}). States with CON regulations had lower crude in‐hospital mortality rates compared with states without CON (1.3% versus 1.5%). In our multivariate analysis, CON status was associated with a modest increase in the composite end point of any adverse outcome (odds ratio: 1.11 \[1.01--1.21\]).

###### 

Proportion of PCI Procedures With Complications by CON Status

  Variable                                                Total    No CON States   CON States   *P* Value                   
  ------------------------------------------------------- -------- --------------- ------------ ----------- -------- ------ --------
  Vascular complications requiring treatment              5554     0.44%           2904         0.43        2650     0.45   0.19
  RBC/Whole blood transfusion                             33 243   2.62            17 637       2.62        15 606   2.63   0.71
  Bleeding event w/in 72 h                                21 075   1.66            10 725       1.59        10 350   1.74   \<0.01
  Stroke                                                  2787     0.22            1496         0.22        1291     0.22   0.57
  Post‐PCI patients requiring emergency or salvage CABG   3662     0.29%           2050         0.30        1612     0.27   \<0.01
  In‐hospital mortality                                   17 958   1.42            9994         1.48        7964     1.34   \<0.01
  Any adverse events                                      84 279   6.64            44 806       6.64        39 473   6.64   0.87

CABG indicates coronary artery bypass grafting; CON, certificate of need; PCI, percutaneous coronary intervention; RBC, red blood cell.

Discussion {#jah33788-sec-0020}
==========

In this cross‐sectional analyses of data from the CathPCI registry, we found that state CON status was associated with a small but statistically significantly lower proportion of PCIs classified as rarely appropriate compared with non‐CON states. Similarly, when we stratified our results by statewide CON stringency, our findings did not vary significantly according to the stringency of CON regulations. Our study also demonstrated that state CON status was associated with a higher risk of selected adverse events. Taken together, our findings suggest that CON regulations may have a limited potential to prevent overuse of invasive cardiac procedures and improve outcomes for these patients.

This analysis builds upon a prior study that examined the relationship between state cardiac CON regulations and procedural appropriateness solely in patients with acute myocardial infarction.[8](#jah33788-bib-0008){ref-type="ref"} Our analysis extends this prior work by replicating the work in ACS patients using contemporary AUC criteria and being the first to characterize the association between CON and appropriateness in PCI patients with stable ischemic coronary disease. This finding is important, as a higher proportion of PCI procedures performed on non‐ACS patients are considered rarely appropriate than in ACS patients, and our present study highlights that the modest association of CON with PCI appropriateness is largely driven by the proportion of PCI done for non‐acute indications. Furthermore, our study is the first to study the association between CON status and PCI appropriateness using contemporary AUC criteria. As such, the proportion of PCIs within each appropriateness category in our study sample differs from previous analyses. Despite this discrepancy, our results are consistent with prior literature in that the absolute differences in procedural appropriateness between CON and non‐CON states are small.

We found that CON status was inconsistently associated with individual PCI complications and mortality rates. However, when we considered all adverse outcomes as a composite, patients treated in CON states were at increased risk of adverse outcomes compared with patients treated in non‐CON states, and this risk appeared driven by increased risk of bleeding. Our findings are consistent with previous studies that suggest an equivocal association between CON regulations and mortality after coronary bypass surgery or cardiac catheterization.[6](#jah33788-bib-0006){ref-type="ref"}, [8](#jah33788-bib-0008){ref-type="ref"}, [17](#jah33788-bib-0017){ref-type="ref"}, [18](#jah33788-bib-0018){ref-type="ref"}, [19](#jah33788-bib-0019){ref-type="ref"} Taken together, these findings raise questions about the effectiveness of CON in improving patient outcomes following PCI. From a policy perspective, the maintenance of CON regulations is not without opportunity cost and should be continued only if there is evidence of improvements in healthcare delivery. Our findings emphasize the importance of regularly analyzing and examining the effectiveness of public policies to ensure they remain relevant and effective.

This study has several limitations that may warrant consideration. First, our cross‐sectional analyses study design cannot discern a cause‐and‐effect relationship between CON status and PCI appropriateness or PCI outcomes. Second, any associations noted in the study may reflect other aspects of healthcare delivery not captured in our analyses and are independent of CON status. Examples of these factors include regional physician practice variation, institutional and hospital policies, and managed care penetration. Statewide mandated public reporting represents another policy that may affect PCI appropriateness in our study. However, the large majority of states with public reporting are also states with CON regulations and therefore, we do not expect significant differences in our results to be attributable to public reporting. Third, there is substantial heterogeneity of the cardiac CON regulations across states. Legal statutes and processes for CON regulations vary by state, and it is challenging to quantify the potential impact of a state\'s regulations on cardiac services. Although we attempted to address this limitation by applying CON stringency to our analyses, the most recent categorization of CON stringency was completed over a decade ago and did not pertain specifically to CON regulations for invasive cardiac procedures. Fourth, our study sample only included patients undergoing PCI and may not be representative of patients undergoing other invasive procedures or diagnostic testing. Our findings of a lack of association between CON status with procedural appropriateness and outcomes also should not be generalized to other facets of CON such as reducing total healthcare expenditure or duplication of services. Additionally, we appreciate that the AUC may not be perfect in capturing true appropriateness. Nevertheless, studies have identified hospital performance on AUC criteria as a clinically important outcome, and the imperfections of AUC criteria presumably would apply equally to both CON and non‐CON states. Finally, a major intent of CON programs is to reduce costs and our analyses could not assess this important outcome.

Conclusion {#jah33788-sec-0021}
==========

CON regulations are associated with small differences in PCI appropriateness and a modest, increased risk of adverse events following PCI procedures. These findings raise questions on the effectiveness of statewide CON regulations in improving the use of PCI and the short‐term outcomes of PCI procedures. This information is relevant to any efforts to reevaluate the potential effectiveness of CON regulations for invasive cardiac procedures.
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